All articles tagged with #itia
Serena Williams criticized the out-of-competition whereabouts testing system as she plans a return, arguing the rules are restrictive, while the ITIA says the protocols haven’t changed and are essential for fair play; the debate mirrors past cases such as Jenson Brooksby’s suspension and Marketa Vondrousova’s ban, highlighting ongoing friction between players and the anti-doping body.
Czech tennis star Markéta Vondroušová, Wimbledon champion in 2023, was suspended for four years by the ITIA after refusing to submit to an anti-doping test at her home during an out‑of‑competition attempt. She claims the tester’s conduct caused mental stress and says she had no valid reason to refuse; the tribunal found no compelling justification, and she can appeal to the Court of Arbitration for Sport.
Former Wimbledon champion Marketa Vondrousova has been banned for four years for refusing an anti-doping test at her home in December 2025. A tribunal found no compelling justification for the refusal, with the suspension ending on June 21, 2030, and a possible appeal to CAS. The ITIA noted that sanctions for refusals mirror those for positive tests and emphasized tester safety and proper identification and protocol.
2023 Wimbledon champion Markéta Vondrousova has been suspended for four years for refusing a random out-of-competition doping test at her home in December 2025; the independent ITIA tribunal found no compelling justification for the refusal; she may appeal to the Court of Arbitration for Sport (CAS); the ban runs until June 21, 2030, barring her from ITF/WTA/ATP events and Grand Slams.
Iga Swiatek, the world No. 2 in women's tennis, is serving a one-month doping ban after testing positive for trimetazidine, a prohibited substance, due to contamination in a melatonin supplement she was taking for jet lag. The International Tennis Integrity Agency (ITIA) ruled her level of fault as minimal, leading to a short ban. The case was kept confidential during the appeal process, as per Tennis Anti-Doping Programme regulations. Swiatek will be eligible to play again from December 4, allowing her participation in the 2025 Australian Open.
Iga Swiatek, a five-time Grand Slam champion, accepted a one-month suspension after testing positive for the banned substance trimetazidine, which she attributed to contamination of a nonprescription medication. The International Tennis Integrity Agency (ITIA) acknowledged her low level of fault, and Swiatek will return to competition soon, having already served most of her suspension. She forfeited her Cincinnati Open prize money and expressed relief at being cleared to continue her career. The WTA supported Swiatek, emphasizing her commitment to clean sport.
Iga Swiatek, the world No. 2 women's tennis player, has been handed a one-month doping ban after testing positive for trimetazidine, a banned substance. The International Tennis Integrity Agency (ITIA) determined her fault was minimal and not intentional, allowing her to compete in upcoming tournaments, including the Australian Open. Swiatek's positive test was linked to a contaminated melatonin supplement. The ban led to her missing several tournaments and losing her No. 1 ranking. The case has raised concerns about tennis's integrity and transparency.
Simona Halep's four-year doping suspension was reduced to nine months by the Court of Arbitration for Sport, allowing her to compete immediately after being exonerated of intentionally taking a performance-enhancing drug. The decision came after a year-and-a-half legal battle and a fight to salvage her reputation, with CAS ruling that her anti-doping violations were not intentional but came from a contaminated supplement. The International Tennis Integrity Agency's aggressive prosecution and delay in resolving the case have raised concerns about the adjudication of doping cases in tennis, with Halep now looking to restart her career after losing significant time and earnings.
Two-time Grand Slam champion Simona Halep's four-year doping ban has been reduced to nine months by the Court of Arbitration for Sport, allowing her to return to tennis soon. The decision comes after an investigation found that the anti-anaemia drug roxadustat entered her body through a contaminated supplement. While one charge was upheld, another regarding irregularities in her athlete biological passport was dismissed. Halep, who has maintained her innocence, is now free to return to the WTA Tour after the backdated ban expired, and she looks set to compete at the highest level again.
Simona Halep, a two-time Grand Slam tennis champion, has been banned from competition for four years by the International Tennis Integrity Agency (ITIA) for violating anti-doping policies. The ITIA accused Halep of using the prohibited substance roxadustat and irregularities in her Athlete Biological Passport. Halep denies any wrongdoing and plans to appeal the suspension, claiming that the substance was detected due to a contaminated supplement. The suspension is backdated and will run from October 7, 2022, to October 6, 2026.
Two-time Grand Slam champion Simona Halep has been banned for four years for two separate anti-doping rule violations, including testing positive for a banned blood-booster at the US Open last year. The International Tennis Integrity Agency (ITIA) provisionally suspended Halep in October 2022 and later accused her of a second doping offense in May for irregularities in her athlete biological passport. Halep, who has won at Wimbledon and the French Open, expressed her distress on social media and has been ineligible to compete in any sanctioned events during her suspension.
Former world No 1 tennis player, Simona Halep, has been charged with a second breach of doping rules by the International Tennis Integrity Agency (ITIA) relating to irregularities in her athlete biological passport (ABP). Halep has already been provisionally suspended since October 2022 after testing positive for the banned blood-booster roxadustat at the US Open last year. The 31-year-old former Wimbledon and French Open champion has denied knowingly taking the banned substance and said she has evidence that proves low quantities of the anti-anaemia drug entered her body because of an authorised supplement that was contaminated.